Generally more affordable compared to injections
The treatment leads to increased GH and insulin-like growth factor-1 (IGF-1) levels, supporting enhanced lipolysis, metabolic function, and body composition
- when there is risk of torsades de pointes, for example in patients with prolonged QT, concomitant administration of other medications that produce torsades de pointes (amiodarone, quinidine, bepridil, IV erythromycin, halofrantine, pentamidine, sparfloxacin, sultopride, vincamine, betrilio, disopyramide, sotalol, etc)
Concentration Methionine 25mg/ml Inositol 50mg/ml Choline 50mg/ml Cyanocobalamin 0.33mg/ml Overview MICC is an injectable solution crafted to enhance the bodys capability to lose fat and boost energy by optimizing metabolic processes